Menu
GWAS Study

Whole-genome association study of antibody response to Epstein-Barr virus in an African population: a pilot.

Sallah N, Carstensen T, Wakeham K et al.

29868224 PubMed ID
GWAS Study Type
3635 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SN
Sallah N
CT
Carstensen T
WK
Wakeham K
BR
Bagni R
LN
Labo N
PM
Pollard MO
GD
Gurdasani D
EK
Ekoru K
PC
Pomilla C
YE
Young EH
FS
Fatumo S
AG
Asiki G
KA
Kamali A
SM
Sandhu M
KP
Kellam P
WD
Whitby D
BI
Barroso I
NR
Newton R
Chapter II

Abstract

Summary of the research findings

Epstein Barr virus (EBV) infects 95% of the global population and is associated with up to 2% of cancers globally. Immunoglobulin G (IgG) antibody levels to EBV have been shown to be heritable and associated with developing malignancies. We, therefore, performed a pilot genome-wide association analysis of anti-EBV IgG traits in an African population, using a combined approach including array genotyping, whole-genome sequencing and imputation to a panel with African sequence data. In 1562 Ugandans, we identify a variant in human leukocyte antigen (HLA)-DQA1, rs9272371 (p = 2.6 × 10-17) associated with anti-EBV nuclear antigen-1 responses. Trans-ancestry meta-analysis and fine-mapping with European-ancestry individuals suggest the presence of distinct HLA class II variants driving associations in Uganda. In addition, we identify four putative, novel, very rare African-specific loci with preliminary evidence for association with anti-viral capsid antigen IgG responses which will require replication for validation. These findings reinforce the need for the expansion of such studies in African populations with relevant datasets to capture genetic diversity.

1,473 Ugandan ancestry individuals, 2,162 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

3635
Total Participants
GWAS
Study Type
No
Replicated
Sub-Saharan African, European
Ancestry
Uganda
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.